Kabra Drugs Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|
| Revenue | TBA | TBA | TBA |
| Operating Expense | 0.55 | 0.37 | 0.11 |
| Net Profit | -0.55 | -0.37 | -0.11 |
| Net Profit Margin | TBA | TBA | TBA |
| Earning Per Share | -1.24 | -0.84 | -0.25 |
| EBIDTA | -0.55 | -0.37 | -0.11 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Jun 2024 |
|---|---|
| Revenue | TBA |
| Operating Expense | 0.55 |
| Net Profit | -0.55 |
| Net Profit Margin | TBA |
| Earning Per Share | -1.24 |
| EBIDTA | -0.55 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | TBA | TBA | TBA |
| Operating Expenses Annual | 0.74 | 0.34 | 0.18 |
| Operating Profit Annual | -0.74 | -0.34 | -0.18 |
| Interest Annual | TBA | TBA | TBA |
| Depreciation | TBA | TBA | 0.01 |
| Net Profit Annual | -0.74 | -0.34 | -0.19 |
| Tax Annual | TBA | TBA | TBA |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | TBA |
| Operating Expenses Annual | 0.74 |
| Operating Profit Annual | -0.74 |
| Interest Annual | TBA |
| Depreciation | TBA |
| Net Profit Annual | -0.74 |
| Tax Annual | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | TBA | TBA | 0.01 |
| Cash Flow from Operations | -0.21 | -0.35 | -0.13 |
| Cash Flow from Investing | TBA | TBA | TBA |
| Cash Flow from Financing | 2.88 | 0.36 | 0.13 |
| Cash Flow at the End | 2.67 | TBA | TBA |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | TBA |
| Cash Flow from Operations | -0.21 |
| Cash Flow from Investing | TBA |
| Cash Flow from Financing | 2.88 |
| Cash Flow at the End | 2.67 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | TBA | TBA | TBA |
| PBIT Margin (%) | TBA | TBA | TBA |
| PBT Margin (%) | TBA | TBA | TBA |
| Net PROFIT Margin (%) | TBA | TBA | TBA |
| Return On Networth / Equity (%) | TBA | TBA | TBA |
| Return On Networth /Employed (%) | TBA | TBA | TBA |
| Return On Assets (%) | TBA | TBA | TBA |
| Total Debt / Equity (X) | 8.83 | TBA | TBA |
| Asset Turnover Ratio (%) | TBA | TBA | TBA |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | TBA |
| PBIT Margin (%) | TBA |
| PBT Margin (%) | TBA |
| Net PROFIT Margin (%) | TBA |
| Return On Networth / Equity (%) | TBA |
| Return On Networth /Employed (%) | TBA |
| Return On Assets (%) | TBA |
| Total Debt / Equity (X) | 8.83 |
| Asset Turnover Ratio (%) | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | TBA | TBA | TBA |
| Total Current Assets Annual | 4.55 | 0.68 | 0.71 |
| Non Current Assets Annual | 0.02 | 0.02 | 0.02 |
| Total Shareholders Funds Annual | 1.08 | -0.73 | -0.39 |
| Total Assets Annual | 4.57 | 0.70 | 0.73 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | TBA |
| Total Current Assets Annual | 4.55 |
| Non Current Assets Annual | 0.02 |
| Total Shareholders Funds Annual | 1.08 |
| Total Assets Annual | 4.57 |
No Data Availabe
